You are here: Industry Insights > Roche

News List

Roche’s Tecentriq/Avastin combo improves survival in liver cancer pharmatimes
January 14, 2021
Roche is planning to present updated data confirming that its immunotherapy combination, consisting of Tecentriq (atezolizumab) and Avastin (bevacizumab), improves overall survival (OS) in patients with a type of liver cancer.
EU OK for Roche’s oral flu treatment Xofluza pharmatimes
January 12, 2021
The European Commission (EC) has approved Roche’s oral treatment Xofluza (baloxavir marboxil) for the treatment of influenza.
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq pharmaceutical-business-review
January 08, 2021
Roche has secured a breakthrough therapy designation from the US Food and Drug Administration (FDA) for tiragolumab plus Tecentriq (atezolizumab) to treat PD-L1-high non-small cell lung cancer (NSCLC).
Roche gets EC nod for Phesgo to treat HER2-positive breast cancer pharmaceutical-business-review
December 30, 2020
Roche has secured approval from the European Commission (EC) for its Phesgo to treat early and metastatic HER2-positive breast cancer.
Roche’s faricimab hits the mark in diabetic macular edema study pharmatimes
December 22, 2020
Swiss pharma company Roche has announced that its investigational bispecific antibody faricimab met the primary endpoint across two phase III studies in diabetic macular edema (DME), a leading cause of vision loss.
Roche reveals new bispecific antibody data in blood cancers pharmatimes
December 10, 2020
Swiss pharma company Roche has revealed positive early data for its investigational bispecific antibodies mosunetuzumab, glofitamab and cevostamab in a range of blood cancer types.
Roche gets FDA approval of Gavreto in advanced or metastatic RET-mutant and RET fusion-positive thyroid cancers pharmaceutical-business-review
December 07, 2020
Roche announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto (pralsetinib) for the treatment of adult and paediatric patients 12 years of age and older with advanced or metastatic rearranged during transfection (RET)-mutant ...
Roche's Xolair gets US nod for nasal polyps treatment pharmatimes
December 03, 2020
Roche’s asthma med Xolair has scored approval from the US Food and Drug Administration (FDA) for the treatment of nasal polyps in adults.
Roche’s Xofluza gets FDA approval for influenza prevention pharmaceutical-technology
November 26, 2020
The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Roche’s Xofluza (baloxavir marboxil) as a treatment to prevent influenza in people aged 12 years and above following post-exposure prophylaxis.
Roche’s arthritis drug shows effectiveness for ill patients in Covid-19 trial pharmaceutical-technology
November 23, 2020
The UK’s Imperial College London has reported that early data from the REMAP-CAP trial showed Roche’s arthritis drug, Actemra (tocilizumab), is expected to reduce deaths and time spent in intensive care in critically ill patients with severe Covid-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page